KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Goodwill (2016 - 2025)

Historic Goodwill for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $16.0 billion.

  • Teva Pharmaceutical Industries' Goodwill rose 563.15% to $16.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $16.0 billion, marking a year-over-year increase of 563.15%. This contributed to the annual value of $16.0 billion for FY2025, which is 563.15% up from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Goodwill stood at $16.0 billion for Q4 2025, which was up 563.15% from $15.9 billion recorded in Q3 2025.
  • Teva Pharmaceutical Industries' 5-year Goodwill high stood at $20.4 billion for Q2 2021, and its period low was $479.0 million during Q2 2022.
  • In the last 5 years, Teva Pharmaceutical Industries' Goodwill had a median value of $17.1 billion in 2023 and averaged $16.6 billion.
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Goodwill tumbled by 9765.44% in 2022, and later skyrocketed by 347369.52% in 2023.
  • Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Goodwill stood at $17.6 billion in 2021, then fell by 2.59% to $17.2 billion in 2022, then changed by 0.0% to $17.2 billion in 2023, then dropped by 11.82% to $15.1 billion in 2024, then grew by 5.63% to $16.0 billion in 2025.
  • Its Goodwill stands at $16.0 billion for Q4 2025, versus $15.9 billion for Q3 2025 and $15.9 billion for Q2 2025.